HedgeChatter

Archives

General, 98 Up Last Year And 22 Winning Trades In A Row #General

General, 98 Up Last Year And 22 Winning Trades In A Row
Select LanguageEnglishAfrikaansAlbanianArabicBelarusianBulgarianCatalanChinese (Simplified)Chinese (Traditional)CroatianCzechDanishDutchEstonianFilipinoFinnishFrenchGalicianGermanGreekHebrewHindiHungarianIcelandicIndonesianIrishItalianJapaneseKoreanLatvianLithuanianMacedonianMalayMalteseNorwegianPersianPolishPortugueseRomanianRussianSerbianSlovakSlovenianSpanishSwahiliSwedishThaiTurkishUkrainianVietnameseWelshYiddish
We have 163 guests online

Continue at source:  

General, 98 Up Last Year And 22 Winning Trades In A Row #General

See which stocks are being affected by Social Media

 […]

January 8, 2015 , , , , , , , , Comments Off on General, 98 Up Last Year And 22 Winning Trades In A Row #General read more

Halozyme Closes In On A Breakout: A Technical Analysis

View gallery.Stocks have been getting hit pretty hard over the last week. The new year has started off somewhat like 2014 did — down.Some individual industries are holding up a little better than others, such as gold miners, REITs and airlines.Biotech stocks have held on relatively well, too.Biotech names such as Agios Pharmaceuticals (NASDAQ: AGIO) and Incyte Corp (NASDAQ: INCY) […]

January 7, 2015 , , , , , , , Comments Off on Halozyme Closes In On A Breakout: A Technical Analysis read more

3 Biotech Stocks That Could Trounce Gilead Sciences, Inc. in 2015

Sovaldi pill. Source: Gilead SciencesGilead Sciences had another phenomenal year in 2014, returning 26% for investors. That’s more than double the return of the broad-based S&P 500 , and it has hepatitis C drug Sovaldi to thank.In just the first nine months of 2014, Sovaldi netted Gilead $8.55 billion in sales. It’s the most effective drug launch in history by […]

January 7, 2015 , , , , , , , , , , Comments Off on 3 Biotech Stocks That Could Trounce Gilead Sciences, Inc. in 2015 read more

Pharma, Biotech Stocks Avoid Much Of Early New Year’s Malaise

In other news, a Food and Drug Administration advisory panel will meet Wednesday to decide whether to recommend approval for a biosimilar drug, which represents a potentially cheaper alternative to Amgen Inc. ’s Neupogen. If it gains agency approval, this drug would be the first biosimilar to get the FDA’s OK and it could mark the beginning of a new […]

January 7, 2015 , , , , , , , , , , Comments Off on Pharma, Biotech Stocks Avoid Much Of Early New Year’s Malaise read more

New ETFs Could Benefit From Favorable Biotech Seasonality

In recent years, there have been many bad times in which to be long biotechnology stocks and exchange traded funds, but with some marquee industry conferences imminent, the biotech industry is in the midst of one of its most potent seasonal periods.December is the second-best month of the year for the broader biotech sector after July, but due to the […]

January 6, 2015 , , , , , , , , , Comments Off on New ETFs Could Benefit From Favorable Biotech Seasonality read more

These stocks look the most promising for January

Read More Why stocks ‘more vulnerable’ in 2015: PaulsenIt might be tempting to try something new altogether, but Sam Stovall of S&P Capital IQ says in a report that one of the best sectors of 2014 is looking good again. The health-care sector has jumped more than 23% during 2014 — making it one of the best places for stocks.And […]

January 5, 2015 , , , , , , , Comments Off on These stocks look the most promising for January read more

3 Biotech Stocks We're Watching Closest Ahead of the JPMorgan Healthcare Conference

Source: GlaxoSmithKline via Flickr.When it comes to healthcare events, there is none more important than the JPMorgan Healthcare Conference. Filled with dozens upon dozens of biotech and medical device companies, the JPMorgan Healthcare Conference, coming up in mid-January, is the perfect time for companies to unveil a study or device they’ve been keeping under their thumb for a rainy day.With […]

January 5, 2015 , , , , , , , Comments Off on 3 Biotech Stocks We're Watching Closest Ahead of the JPMorgan Healthcare Conference read more

‘Tis the Season for Biotech ETFs

Over the last several years, there has rarely been a bad time to own biotechnology exchange traded funds. That much is confirmed by the presence of multiple biotech ETFs on the annual lists of the top 10 sector funds.In 2014, each of the five major biotech ETFs ranked among the year’s top 10 sector ETFs. That includes the First Trust […]

January 5, 2015 , , , , , , , Comments Off on ‘Tis the Season for Biotech ETFs read more

These 3 Biotech Stocks Tripled Investors' Money in 2014

Life-changing financial gains are usually generated over the long haul, not in one year. However, sometimes stocks can put up eye-popping returns over a short period of time and when they do they can have a huge impact on investor’s portfolios. For example, these three healthcare stocks tripled investor’s money last year and while no one can know if they’ll […]

January 4, 2015 , , , , , , , , , , Comments Off on These 3 Biotech Stocks Tripled Investors' Money in 2014 read more

Prana Biotechnology joins other biotech companies in the doldrums

” itemprop=”image”/>Share prices of biotech stocks are hitting the wall at the rate of one a week, with Prana Biotechnology the latest company to suffer. Its shares were dumped on Tuesday after poor research results.The shares dived 74 per cent, hitting the pockets of some of the country’s wealthiest families and wiping out a remarkable surge that had seen its […]

January 4, 2015 , , , , , , , Comments Off on Prana Biotechnology joins other biotech companies in the doldrums read more